Canada VC Funds

2048 Ventures is a venture capital firm founded in 2018 and headquartered in New York, NY. The firm focuses on early-stage investments, particularly in technology-driven startups. They have a strong portfolio with over 120 investments across diverse sectors, including biotechnology, artificial intelligence, health tech, and commercial products. Some notable companies backed by 2048 Ventures include Adaptis Technologies, an AI-powered platform for optimizing the carbon footprint of buildings, and Fathom Optics, which delivers 3D experiences using standard printing technologies. Their investment strategy is to support visionary founders at the earliest stages, often leading pre-seed and seed rounds. 2048 Ventures has shown significant activity, with their portfolio companies collectively raising $591 million and reaching a valuation of $2.6 billion by the end of 2023. They have invested in innovative companies like TwoStep Therapeutics, which specializes in modular peptide technology for targeting solid tumors, and Century Health, which leverages AI to accelerate drug development​.

2150 is a London, Copenhagen, and Berlin-based venture capital firm focused on transforming urban environments through sustainable technology. With a €268 million fund, 2150 invests in companies that address major challenges across the "Urban Stack"—everything from the design and construction of cities to how they are powered and maintained. Their mission is to support groundbreaking startups that can reimagine urban living, while significantly reducing carbon emissions and improving sustainability. 2150 primarily invests in Series A and B stage companies, with check sizes ranging from $1 million to $7 million. Their focus spans climate tech, green solutions, and innovative materials, all aimed at creating smarter, more efficient cities. The firm’s portfolio includes companies like CarbonCure, which injects recycled CO₂ into concrete to reduce its carbon footprint, Normative, a platform that helps businesses track and manage their carbon emissions, and Ampd Energy, which electrifies construction sites to minimize pollution. Beyond financial backing, 2150 takes a hands-on approach, working closely with founders to scale their businesses and maximize impact. The firm’s ultimate goal is to build a portfolio capable of mitigating gigatonnes of CO₂ emissions, comparable to the entire annual output of countries like Germany and France. With strong backing from investors like Novo Holdings and the BMW Foundation, 2150 is positioned as a key player in the future of urban development, driving both commercial success and global sustainability.

3M Ventures, the corporate venture capital arm of 3M, focuses on investing in early-stage companies that align with 3M's strategic priorities. These priorities include automotive electrification, safety, home improvement, consumer electronics, climate tech, sustainable packaging, industrial automation, and semiconductor and data center technologies. Their investment strategy targets companies with strong intellectual property, demonstrated commercial traction, and robust management teams​. Notable investments by 3M Ventures include GrayMatter Robotics, Moxe Health, and Metalenz, which span across artificial intelligence, healthcare, and 3D technology, respectively. 3M Ventures seeks to not only provide financial investment but also leverage 3M's extensive technological platforms, manufacturing capabilities, and global networks to help scale their partner companies​. 3M is also heavily committed to sustainability. The company has pledged $1 billion to achieve carbon neutrality, reduce water use, and improve water quality by 2030. This initiative includes implementing state-of-the-art water purification technology and developing innovative solutions for renewable energy and emissions reduction​.

500 Global, formerly known as 500 Startups, is a prominent venture capital firm with a robust global presence and over $2.4 billion in assets under management. Since its inception in 2010, it has invested in more than 2,800 companies across 80+ countries. Some of its most notable investments include Credit Karma, Twilio, Canva, Grab, Bukalapak, The RealReal, Talkdesk, Udemy, and Ipsy​​. 500 Global's industry focus spans various sectors, with significant investments in consumer services, software-as-a-service (SaaS), fintech, and media​ (Proptech Zone)​. Its geographic focus is truly global, with operations in major innovation hubs such as Silicon Valley, New York, London, Singapore, and Mexico City, as well as emerging markets like Lagos, Jakarta, and Riyadh​​. The fund's strategy involves early-stage investments, providing seed capital along with comprehensive support through its Seed Accelerator Programs. These programs emphasize digital marketing, customer acquisition, lean startup methodologies, and fundraising strategies. 500 Global prefers to invest in companies with high growth potential and innovative business models​. Typically, 500 Global invests an average of $150,000 to $250,000 in initial seed rounds and often leads these rounds. The firm is known for its hands-on approach, leveraging its extensive network of mentors, industry experts, and alumni to support portfolio companies. Recently, 500 Global has been active in launching thematic funds targeting specific industries and regions, further expanding its investment reach​​. The leadership team includes Christine Tsai, the CEO and Founding Partner, who has steered the firm’s growth and global expansion. 500 Global's diverse team of over 100 members spans more than 30 countries, bringing a wealth of experience as entrepreneurs, investors, and operators from leading tech companies​.

AAF Management Ltd., founded in 2016 and headquartered in Washington, D.C., is a prominent early-stage venture capital firm. The firm focuses on pre-seed, seed, and Series A stage technology companies in North America, with particular emphasis on sectors such as fintech, healthcare, consumer tech, enterprise software, and deep tech. AAF Management has an impressive portfolio of over 120 venture-backed companies. Notable investments include Robinhood, Didi, Savage X Fenty, StockX, Figure, Reddit, Current, Synthego, Jasper, and Drata. The firm has also celebrated significant exits, such as CrowdStrike (NASDAQ: CRWD), TruOptik (acquired by TransUnion), Even Financial (acquired by MoneyLion), Prodigy (acquired by Upstart), Portfolium (acquired by Instructure), and HeyDoctor (acquired by GoodRx). The firm is backed by over 95 limited partners, including family offices, royal families, C-level executives, and hedge fund managers from the US, Europe, and MENA regions. AAF Management prides itself on its strategic value-add, leveraging a vast network to support its portfolio companies and emerging managers globally.

Accel is a renowned venture capital firm known for its strategic investments across various stages and sectors. Founded in 1983, Accel has played a pivotal role in the success of numerous high-profile companies. Some of its most notable investments include Facebook, Dropbox, Spotify, and Slack, showcasing its strength in identifying and backing transformative technology companies early on. The firm's investment strategy focuses on seed and Series A funding, ensuring deep engagement with startups from their inception. Accel emphasizes a collaborative approach, providing not just capital but also mentorship and strategic support to help entrepreneurs build market-defining businesses. This hands-on involvement has led Accel to lead investments in over 70% of its portfolio companies​. Accel operates globally, with key offices in Silicon Valley, London, and Bangalore, enabling it to tap into entrepreneurial talent worldwide. The firm has recently closed on several funds totaling $3.05 billion, aimed at supporting early-stage startups and growth rounds for more mature companies​​. In 2023, Accel made significant investments in companies like Blackpoint Cyber, Headway, and Cyera, reflecting its commitment to diverse sectors such as cybersecurity, mental health, and data protection​​. This broad sector focus, combined with a global investment perspective, positions Accel as a key player in the venture capital landscape, continuously driving innovation and supporting exceptional entrepreneurs around the world.

Accion Venture Lab is an early-stage venture fund focused on empowering inclusive fintech startups that serve underserved and low-income populations globally. Established as part of Accion, a nonprofit dedicated to financial inclusion, Venture Lab provides seed-first capital paired with extensive strategic and operational support to help startups scale and overcome early challenges. Their diverse portfolio features innovative companies like Apollo Agriculture, which offers tech-driven financing to smallholder farmers in Kenya and Zambia, and Bababos, an Indonesian platform that supports small-scale manufacturers with raw materials and financing solutions. With a geographic reach that spans Latin America, the Caribbean, sub-Saharan Africa, the Middle East, North Africa, Southeast Asia, and even parts of the U.S., Accion Venture Lab's commitment is global. The fund targets industries such as digital lending, insurtech, personal financial management, and MSME-focused solutions, identifying startups with a mission to address systemic barriers to financial access. Their strategy is unique in that they prefer being the first institutional investor, ensuring startups receive not just capital but high-touch mentorship and strategic guidance. In 2019, Accion Venture Lab boosted its support efforts by launching a $23 million fund aimed at deepening their investment into inclusive fintech. Their approach prioritizes not only financial backing but also leveraging their deep-rooted expertise in financial inclusion to provide hands-on operational assistance. The team is led by seasoned Managing Partners Amee Parbhoo and Rahil Rangwala, who bring years of experience in fintech, impact investing, and scaling social enterprises. Founders looking for support from Venture Lab should demonstrate impactful, scalable solutions with clear pathways to financial inclusion.

ACME Capital is a prominent venture capital firm based in San Francisco, specializing in early-stage investments in disruptive technologies and innovative business models. Founded in 2013 by Hany Nada, Shervin Pishevar, and Scott Stanford, the firm focuses on sectors such as healthcare, financial services, and space exploration. Their notable investments include high-profile companies like Uber, Slack, and DraftKings, demonstrating a knack for identifying and nurturing industry leaders. ACME Capital's investment strategy is centered on supporting visionary founders who are tackling large-scale challenges with groundbreaking solutions. They emphasize platform shifts and technology breakthroughs that promise significant societal benefits. The firm typically leads funding rounds and provides not just capital, but also strategic guidance and operational support to help startups scale effectively. Geographically, ACME Capital has a strong focus on the United States, but their portfolio also includes companies with a global reach. Their commitment to diversity and inclusion is reflected in their investment choices, with a significant portion of their portfolio companies led by underrepresented founders. The team at ACME Capital includes experienced partners like Brian Yee and Alexander Fayette, who bring a wealth of expertise and a hands-on approach to their investment process. Entrepreneurs looking to engage with ACME Capital are encouraged to present bold, transformative ideas that have the potential to disrupt massive markets and drive significant impact.

Action Potential Venture Capital (APVC) is a leading medical technology venture capital firm founded by GlaxoSmithKline (GSK) in 2013. The firm focuses on advancing bioelectronic medicines and enabling technologies. APVC is headquartered in Cambridge, Massachusetts, with additional offices in Scotts Valley, California. APVC invests in companies that leverage advances in hardware, computing, and material science to regulate neural or cellular activity, aiming to treat a range of chronic diseases. Notable portfolio companies include Cala Health, which develops non-invasive neuromodulation therapies for conditions like essential tremor; CVRx, known for its FDA-approved BAROSTIM NEO therapy for heart failure; and Neuspera Medical, which is developing minimally invasive neuromodulation therapies for overactive bladder. The firm takes a hands-on role on the boards of startups, providing strategic guidance and support. APVC has made 25 investments to date, with recent notable investments in Exo, which offers AI-enabled handheld ultrasound imaging, and MicroTransponder, which focuses on therapies for neurological conditions. APVC's investment approach emphasizes diversity and inclusion within the healthcare and entrepreneurial communities. The leadership team includes Imran Eba and Juan-Pablo Mas, who bring extensive experience in venture capital and biotechnology investments.

Acumen is a pioneering impact investment firm dedicated to addressing poverty through a unique approach it calls “patient capital,” designed to fund social enterprises that serve the most marginalized populations. Since its inception in 2001 by Jacqueline Novogratz, Acumen has invested over $150 million across 150+ companies worldwide. Its portfolio spans essential sectors like clean energy, agriculture, healthcare, and education, all aimed at empowering low-income communities with sustainable solutions that can operate at scale. Acumen’s methodology combines financial investment with a strong emphasis on management and leadership support. By focusing on long-term growth rather than immediate returns, Acumen supports businesses in emerging markets like East and West Africa, India, Latin America, and the U.S., ensuring they grow in both impact and profitability. Some of their prominent initiatives, such as off-grid energy projects in sub-Saharan Africa and affordable healthcare solutions in South Asia, reflect their commitment to transforming critical services for underserved populations. In addition to financial investment, Acumen fosters a culture of moral leadership through Acumen Academy, which educates entrepreneurs and social innovators on creating impactful and inclusive businesses. This dual approach of investment and training allows Acumen to build a pipeline of leaders and companies equipped to drive systemic change. With an extensive global network and partners ranging from corporate foundations to local entrepreneurs, Acumen continually expands its reach, working tirelessly to reimagine the role of capital in tackling poverty.

AENU is a venture capital fund that’s making waves by focusing on early-stage climate tech companies, aligning profitability with environmental and social impact. Based in Europe, AENU primarily invests in startups that tackle the climate crisis through innovations in energy transition, carbon economy, and sustainability. Their portfolio includes impactful companies such as Alcemy, Monta, Ocell, Trawa, and Hometree, which work on solutions ranging from low-carbon cement to intelligent energy management. With a geographic focus on Europe, especially the DACH region, Nordics, and the UK, AENU targets Seed and Series A investments, typically writing checks between €1-4 million. They often co-lead or lead rounds and always aim for board representation to ensure a strategic partnership. Their innovative Impact-as-a-Service (IaaS) offering helps portfolio companies scale while maintaining strong environmental, social, and governance (ESG) standards. Founded by Fabian Heilemann and Ferry Heilemann, AENU boasts a team of seasoned entrepreneurs and investors with a proven track record of scaling ventures. The fund is committed to systemic transformation within venture capital, pushing for stakeholder alignment and equitable growth. Startups looking to partner with AENU should expect a research-driven, high-impact approach, where both financial returns and climate outcomes are equally prioritized​.

Afore Capital is a San Francisco-based venture capital firm specializing in pre-seed stage investments. Founded in 2016, Afore Capital manages a $300 million fund and typically invests $500,000 to $2 million in early-stage companies that are pre-traction and pre-revenue. The firm focuses on identifying high-potential startups and helping them rapidly scale towards Series A funding rounds. Afore Capital’s diverse portfolio includes companies across sectors such as SaaS, fintech, healthcare, consumer, and enterprise technology. Notable investments include Neo Financial, a digital bank; BetterUp, a platform for professional coaching; and Curefit, a provider of digital and offline fitness services. The firm has a strong track record, with several successful exits and notable co-investments alongside top venture funds like Andreessen Horowitz and Accel​.

Aglaé Ventures is a global technology-focused investment firm established in 2017, with headquarters in Paris and offices in New York and San Francisco. The firm is backed by Agache (formerly Groupe Arnault), the principal investment vehicle of Bernard Arnault, the controlling shareholder of LVMH. Aglaé Ventures invests in fast-growing tech companies at all stages, from seed to pre-IPO rounds, with investment sizes ranging from €100K to €100MM. Notable investments by Aglaé Ventures include high-profile companies such as Airbnb, Slack, Spotify, and Lyft. The firm is sector-agnostic but concentrates on asset-light and scalable business models, particularly in marketplaces, SaaS, content platforms, consumer apps, and digitally native vertical brands. Aglaé Ventures emphasizes a long-term investment approach, providing flexible and enduring capital while supporting portfolio companies with expertise in growth management, brand building, digital marketing, and global expansion strategies. The firm also leverages its extensive network, including access to the LVMH ecosystem, to accelerate the growth of its portfolio companies. The team at Aglaé Ventures includes experienced investors and entrepreneurs like Miyuki Matsumoto, Managing Partner and Head of US Investments, and co-founders Cyril Guenoun and Antoine Loison. The firm prides itself on its simple investment terms and quick decision-making processes, making it an attractive partner for ambitious founders​.

Alabaster Co. is a publishing company founded in 2016 that blends creativity, beauty, and faith to create visually stunning editions of the Bible and other religious texts. The company was started by Brian Chung and Bryan Ye-Chung, who shared a vision of making the Bible more accessible and engaging, particularly in a world increasingly influenced by visual culture. Their beautifully designed Bibles integrate visual imagery with thoughtful design, transforming traditional biblical texts into artful experiences that resonate with modern readers. Alabaster's mission is to present the story of God as not only spiritually enriching but also aesthetically beautiful. This approach reflects their belief that beauty plays a crucial role in deepening one's connection with faith. The company's products are intended to invite readers into a deeper, more contemplative engagement with the Scriptures, helping them see the Bible in a new light. In addition to Bibles, Alabaster Co. has expanded its offerings to include devotionals, Bible studies, and other home goods, all designed with the same commitment to beauty and quality. Their work has sparked conversations about faith and beauty, making their products popular not just for personal use but also as conversation pieces in homes.

Aleph VC, founded in 2013 and based in Tel Aviv, is a prominent venture capital firm focused on early-stage investments in Israeli entrepreneurs. With $850 million under management, Aleph specializes in sectors such as fintech, digital health, cybersecurity, AI, and machine learning. The firm aims to build impactful global brands by providing strategic guidance and access to global markets. Notable investments in Aleph's portfolio include Lemonade, a global insurance company powered by AI and behavioral economics; Melio, which offers digital payment tools for small businesses; and Nexar, a dashcam and edge-AI platform for improved driving. Aleph has also backed companies like Freightos, a digital freight marketplace, and Placer.ai, a leader in location analytics. Aleph's investment strategy typically involves seed and early-stage funding, with investment sizes ranging from $2 million to $12 million. The firm has a strong track record of successful exits, including the public offerings of companies like Lemonade and Monday.com, and acquisitions such as Raftt by Wiz. The team at Aleph is led by co-founders Michael Eisenberg and Eden Shochat, along with partners Yael Elad and Tomer Diari. They leverage their extensive network and expertise to help portfolio companies grow and succeed on a global scale. Aleph's focus on innovation and strong support for its portfolio companies has established it as a leading venture capital firm in Israel​.

Alexandria Real Estate Equities, Inc. (NYSE: ARE) is a prominent real estate investment trust (REIT) specializing in collaborative life science campuses. Founded in 1994, Alexandria is a pioneering force in the life science real estate niche, owning, operating, and developing innovative campuses in major urban locations known for their scientific and technological advancements. The company's extensive portfolio spans key innovation clusters across North America, including Greater Boston, San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. As of March 31, 2024, Alexandria's total market capitalization is $34.4 billion, with an asset base of 74.1 million square feet, which includes operating properties, properties under construction, and planned development projects. Alexandria's success is built on its proven cluster model, which integrates essential components such as strategic location, cutting-edge innovation, top-tier talent, and substantial capital. This model has allowed the company to create and nurture thriving life science ecosystems that facilitate groundbreaking research and development in fields such as biotechnology, pharmaceuticals, and agtech. In addition to real estate, Alexandria operates several strategic verticals, including Alexandria Venture Investments, which invests in disruptive life science companies, and a strong focus on corporate responsibility, promoting sustainability and social impact initiatives. The company's mission-driven approach and operational excellence make it a trusted partner for nearly 800 tenants, driving stable and resilient cash flows through high-quality, long-term leases with diverse tenants.

Aligned Climate Capital is a venture capital firm based in New York, with a sharp focus on investments that drive the decarbonization of the global economy. Founded in 2019 by veterans of the U.S. Department of Energy’s Loan Programs Office, Aligned has quickly established itself as a leader in climate-related investments, managing over $1.8 billion in assets across three primary strategies: venture capital, distributed solar, and climate infrastructure. Aligned's investment strategy revolves around identifying and backing companies that contribute to significant environmental impact while delivering strong financial returns. Notable investments include UtilityAPI, Sealed, and SWTCH, which are involved in energy services, consumer services, and commercial services, respectively. The firm tends to focus on later-stage ventures and infrastructure projects within the United States and Canada. The team, led by CEO Peter Davidson and COO Brendan Bell, leverages their deep expertise in finance and renewable energy to guide their portfolio companies towards growth and impact. The firm is headquartered in New York and Los Angeles, with a small but highly specialized team dedicated to aligning the success of their investments with the broader goal of mitigating climate change.

Alliance Ventures is the strategic venture capital arm of the Renault-Nissan-Mitsubishi Alliance, one of the largest automotive groups globally. Launched in 2018, the fund focuses on investing in innovative startups that are transforming the future of mobility. With headquarters in Amsterdam and offices in key innovation hubs such as Silicon Valley, Paris, Yokohama, and Tel Aviv, Alliance Ventures targets early-stage companies developing technologies related to new mobility, autonomous driving, electric vehicles (EV), energy solutions, and connected services. The fund, with an initial capital of $200 million, primarily invests in Series A and B rounds, helping startups scale through strategic collaborations within the Alliance’s vast automotive ecosystem. Notable investments include companies like WeRide (autonomous driving in China), Enevate (battery technology), and The Mobility House (smart charging and energy storage). Alliance Ventures leverages its extensive network to provide not only capital but also partnerships and market access to accelerate startup growth. Led by a seasoned team, including General Secretary Véronique Sarlat-Depotte and Partner Ryan Armbrust, the fund actively supports startups through every growth phase, from early innovation to commercial scaling, aiming to integrate cutting-edge solutions into the Renault-Nissan-Mitsubishi operations.

Allianz X, the digital investment arm of Allianz Group, focuses on investing in digital growth companies relevant to insurance and asset management. Since its inception, Allianz X has grown its portfolio to over 25 companies with assets under management exceeding €2 billion. The firm has identified 12 unicorns within its portfolio, showcasing its strategic investment acumen. Headquartered in Munich, Allianz X supports companies primarily in the insurtech and fintech sectors, aiming to foster innovations that complement Allianz Group's core businesses. Their investment approach includes late-stage funding, helping mature companies reach their next growth milestones. Key portfolio companies include WeLab, a leading digital financial service provider in Asia, and Pie Insurance, a digital provider of workers' compensation insurance in the U.S. Allianz X has been involved in significant funding rounds, such as co-leading a $250 million Series F investment in Coalition, Inc., a cyber insurtech company, and leading funding for London-based fintech OpenGamma. Their strategy also includes facilitating collaborative partnerships within the digital ecosystem to drive innovation and growth​.

Technology Transfer Venture Capital (TTV) is a Canadian VC fund dedicated to fostering innovation through strategic investments in early-stage and growth-stage companies. TTV focuses on startups that leverage groundbreaking technologies across various sectors, including clean energy, healthcare, and digital infrastructure. The fund aims to support companies that demonstrate strong potential for scalability and significant market impact. TTV has a keen interest in businesses with sustainable and economically durable models. Their portfolio includes notable investments in companies developing technologies aligned with the United Nations Sustainable Development Goals, emphasizing sectors such as clean water, affordable energy, and sustainable cities. Their investment strategy involves providing capital and extensive support, from seed to later stages, ensuring that portfolio companies receive the necessary resources to thrive. TTV typically looks for companies that can present a clear path to market leadership and exhibit a robust business strategy and innovative solutions. The team at TTV, led by experienced professionals such as Senior Managing Partner Joseph Regan and Partner Geoff Catherwood, brings decades of expertise in venture capital and a deep understanding of the technology landscape. They are based in various locations across Canada, ensuring a wide geographic reach and local market knowledge. For startups seeking funding, TTV values approaches that highlight innovative solutions, detailed market evaluations, and strong leadership teams. They prefer companies that are ready to scale and have a compelling sustainability narrative, positioning them as global leaders in their respective fields.

Alon MedTech Ventures is a leading venture capital firm based in Israel, focusing on the incubation and growth of early-stage medical device companies. Founded and chaired by Dr. Shimon Eckhouse, a well-known inventor and entrepreneur in the medical technology sector, Alon MedTech plays a critical role in advancing innovative healthcare solutions that aim to improve global well-being. The firm operates as part of Israel’s Innovation Authority incubator system, providing startups with not only financial backing but also strategic guidance, access to state-of-the-art facilities, and industry expertise. Alon MedTech's investment strategy emphasizes novel technologies that have the potential to revolutionize medical practices and patient outcomes. Alon MedTech’s portfolio includes a variety of groundbreaking companies, such as Hallura, which is developing next-generation hyaluronic acid dermal fillers using a unique crosslinking technology, and SofWave, which offers non-invasive skin tightening solutions using ultrasound technology. The firm’s approach is highly hands-on, working closely with entrepreneurs from the ideation stage through to commercialization, ensuring that these companies can scale successfully and impact the healthcare industry globally. The firm’s commitment to innovation and deep engagement with portfolio companies has positioned it as a key player in the medical device sector, particularly within Israel’s vibrant tech ecosystem.

Alpaca VC is a dynamic seed-stage venture capital firm headquartered in New York, known for its unique approach of investing at the intersection of the physical and digital worlds. Founded by experienced entrepreneurs, Alpaca VC focuses on transforming traditional industries through technology. Their notable investments include Minibar Delivery, ClassPass, and Transfix, reflecting their diverse portfolio in sectors such as proptech, marketplaces, and e-commerce. Alpaca VC primarily targets investments in North America, with a strong emphasis on real estate and commerce startups. They follow a thematic, research-driven strategy, leveraging their extensive network and firsthand experience to support founders. The average investment size ranges from $1 million to $2 million, and they often lead seed rounds​. The firm is led by a team of seasoned professionals, including General Partners Daniel Fetner and David Goldberg, who bring deep expertise from their entrepreneurial and investment banking backgrounds. This leadership team is committed to providing hands-on support and strategic guidance to their portfolio companies. For startups looking to engage with Alpaca VC, the firm values founders who are tackling non-obvious markets with innovative solutions. They prefer to build long-term relationships, offering not just capital but also valuable industry connections and operational support. Alpaca VC is known for its rigorous selection process and high level of engagement with its investments, ensuring that they can significantly contribute to each startup’s growth and success​.

AI Capital is a venture capital firm based in Denver, with operations spanning North America, Europe, and Asia. It focuses on early-stage investments in AI-driven companies, particularly in enterprise software and data platforms. The firm’s primary industry targets are healthcare, life sciences, and core industries like energy and manufacturing, where AI can optimize supply chains and critical services. Additionally, AI Capital invests heavily in cybersecurity, recognizing its importance across these sectors. The firm typically invests in Seed to Series B rounds, bringing a strong combination of technical expertise and deep investment experience. Recent notable portfolio companies include Link3D, Syndesis Health, and Luminoso. AI Capital emphasizes transformative AI applications, from VR therapy to advanced genomic solutions. They aim to support companies with high growth potential and significant societal impact. The firm is led by experienced partners like Neville Teagarden and Andrew Maus, with a team composed of AI specialists and seasoned investors. They value companies solving real-world problems through breakthrough AI technologies. AI Capital often leads rounds and is known for being highly involved with its portfolio companies, offering both strategic and operational support. Founders are encouraged to approach them through established networks or referrals, particularly those innovating in AI's frontier sectors.

AM Ventures is a leading venture capital firm focused on the industrial 3D printing sector, also known as additive manufacturing. Established in Germany, AM Ventures supports early-stage startups worldwide that are innovating in areas such as materials, software, hardware, and applications related to 3D printing. The firm is renowned for its deep industry expertise and extensive global network, which spans 13 countries across four continents. The firm’s investment strategy is centered on empowering entrepreneurs who are developing next-generation technologies that can address major global challenges, including climate change, medical advancements, and digital manufacturing. AM Ventures typically invests between €500,000 and €3 million, focusing on companies from the seed stage to growth phases. In 2022, AM Ventures launched a €100 million venture capital fund dedicated to furthering its commitment to industrial 3D printing. This fund is the first of its kind, emphasizing the firm’s leadership in the additive manufacturing industry and its dedication to driving sustainable innovation on a global scale. The firm partners closely with its portfolio companies, offering not just financial backing but also strategic support and industry connections to help these startups thrive.

Amadeus Capital Partners is a prominent global venture capital firm based in London, established in 1997 by Anne Glover and Hermann Hauser. The firm has built a strong reputation for investing in high-growth technology companies across various sectors, including artificial intelligence, cybersecurity, digital health, fintech, and semiconductors. Amadeus Capital Partners focuses on different stages of investment, providing seed, early-stage, and growth capital to companies with the potential to become global leaders. They are particularly interested in businesses with innovative intellectual property (IP) and those addressing significant, underserved market needs. The firm supports its portfolio companies with both capital and strategic guidance, aiming to build companies that can expand globally. Some of the notable investments include companies like Riverlane, which focuses on quantum computing, and Graphcore, known for its AI hardware solutions. Amadeus Capital Partners has made over 340 investments and has successfully exited over 110 companies, including high-profile exits such as Lumeon and Brytlyt. The firm’s investment approach emphasizes backing great teams, fostering innovation in billion-dollar markets, and scaling businesses to achieve global impact. With a team of over 40 professionals and a strong network of co-investors, Amadeus continues to be a significant player in the venture capital landscape, driving technological advancements across various industries​.

The Amazon Industrial Innovation Fund (AIIF) is Amazon’s $1 billion venture fund focused on advancing technologies that reshape fulfillment, logistics, and supply chain sectors. Established in 2022, the fund invests in companies across various stages, from startups to established players, that bring innovative solutions to areas like warehouse automation, robotics, and artificial intelligence. AIIF's goal is to enhance Amazon’s operations, with an emphasis on employee safety, efficiency, and customer satisfaction. Under the leadership of Franziska Bossart, the fund is expanding its scope in 2024 to target additional areas such as autonomous vehicles and last-mile delivery tech. Key investments have included companies like Agility Robotics, which develops bi-pedal robots for warehouse operations, and Vimaan, specializing in computer vision for inventory management. AIIF’s investments in companies such as Modjoul, which creates wearable safety devices, highlight its commitment to fostering technologies that support workplace safety while advancing automation. AIIF aims to support high-quality companies globally, not limited to Amazon's internal needs, as it seeks broader improvements in industrial automation and supply chain management. This makes AIIF a significant player in the field of corporate venture capital, uniquely positioned to drive impactful innovations while improving Amazon’s logistics capabilities and operational safety.

Amplitude Ventures is a Montreal-based venture capital firm, founded in 2018, that focuses on precision medicine, investing at the intersection of biology and AI. The firm aims to support and scale companies that drive significant advancements in healthcare, particularly within Canada's innovation-rich ecosystem. Notable investments include Zymeworks, a biopharmaceutical company specializing in protein therapeutics, which went public in 2017, and Milestone Pharmaceuticals, known for its treatment for cardiovascular conditions, which also went public in 2019. Other key investments are DrugBank, a comprehensive drug database, and Valence Labs, which was acquired by Recursion. Amplitude Ventures recently closed a $263 million fund, significantly enhancing their capacity to invest in and grow cutting-edge precision medicine companies. The firm operates with a hands-on approach, providing strategic guidance and leveraging a strong network of industry experts. The leadership team includes co-founders Dion Madsen, Jean-François Pariseau, and Bharat Srinivasa, who bring extensive experience in life sciences and venture capital, ensuring robust support for their portfolio companies.

Angeleno Group, founded in 2001 and based in Los Angeles, is a venture capital firm specializing in growth capital for next-generation clean energy and climate solutions companies. With a strategic focus on sectors such as renewable energy, energy storage, sustainable mobility, and carbon mitigation, Angeleno Group aims to address critical global challenges posed by climate change. The firm leverages its extensive industry experience and longstanding relationships to support high-growth, innovative businesses. Angeleno Group invests opportunistically, typically deploying between $10 million and $30 million per opportunity, and focuses on companies with proven technologies and established customer traction. Their portfolio includes a diverse array of companies such as Fictiv, Span, and Anza RE, highlighting their commitment to fostering sustainable and transformative technologies. Angeleno Group's investment strategy is deeply rooted in creating value through active engagement with portfolio companies, providing support in product development, business strategy, sales, and corporate finance. The firm's approach is sector-focused, research-driven, and designed to build a diversified and high-return portfolio.

AngeliCo Ventures is a London-based venture capital firm and investment banking boutique founded in 2008. The firm specializes in healthcare, life sciences, and technology investments, targeting seed to growth-stage companies. AngeliCo Ventures focuses on sectors including digital health, therapeutics, diagnostics, medical devices, robotics, clean energy, and alternative care. The firm is known for its integrated strategy and investment banking solutions, offering services such as capital markets, mergers and acquisitions, strategic advisory, and research. AngeliCo Ventures prides itself on its extensive experience, having completed over $1.6 billion in transactions and raising $465 million for clients. Their approach emphasizes a strong relationship with research institutes and universities, providing early insights into high-potential discoveries. This connection helps AngeliCo Ventures to identify and support promising investment opportunities, guiding companies from inception through various stages of financing and strategic development.

ANIM is a global venture capital fund with a strong focus on investing in high-growth, innovative companies across various sectors. Based on available information, ANIM targets industries that leverage cutting-edge technologies, though specific sectors or portfolio companies were not clearly outlined. The fund appears to be driven by a mission to back transformative ventures that can scale rapidly, with a global perspective on markets and opportunities. ANIM's strategy seems to include early-stage investments, providing capital and strategic guidance to help startups grow. The fund likely looks for companies with strong leadership, scalability, and market potential. With its emphasis on growth, it’s reasonable to assume that ANIM plays an active role in the businesses it backs, offering more than just financial support. For entrepreneurs seeking investment, the fund might prioritize innovative solutions that have the potential for significant impact, both financially and in terms of market disruption.

Animo Ventures is a venture capital firm dedicated to backing early-stage founders who are passionate and willing to go all in. Based in Miami with additional offices in New York and San Francisco, Animo focuses on pre-seed and seed investments in the U.S., cutting checks that range from $500,000 to $2.5 million. The firm actively invests in sectors like fintech, enterprise software, digital health, B2B, and consumer-facing technology, aiming to nurture high-growth startups from ideation to early traction​. What sets Animo apart is its radically founder-focused approach. The firm operates without layers of analysts or associates, meaning founders work directly with general partners throughout the investment process. The team, led by Nico Berardi and Antonio Osio, is deeply involved in all aspects of the startups they back, offering not only capital but also strategic guidance. Animo reserves a significant portion of its fund for follow-on investments, ensuring long-term support​. Animo’s portfolio includes notable companies such as Nearpod, Intello, Morty, and Ironclad, with a particular focus on fintech and enterprise SaaS. The firm is not only a financial backer but also acts as a strategic partner, leveraging a dense network of connections to help with fundraising, hiring, and scaling. With its "people backing people" ethos, Animo builds genuine, long-term relationships with founders, committed to seeing them succeed through every challenge and milestone​.

Anorak Ventures, founded in 2016 and headquartered in San Francisco, is a seed-stage venture firm that focuses on investing in transformative technology and people. The firm primarily invests in pre-seed and seed-stage companies across various technology sectors, including artificial intelligence and machine learning (AI/ML), Internet of Things (IoT), robotics, and consumer tech. Anorak Ventures has invested in over 120 seed-stage technology companies, which now represent an aggregate market capitalization of $24.8 billion. Notable investments in their portfolio include companies such as Vantage Point, WeatherCheck, Orderful, Framework, Prisms VR, Better Health, and Marxent. They are dedicated to helping these companies achieve product-market fit and secure follow-on financing. The firm, led by Managing Partner Greg Castle, aims to support innovative startups by providing not just capital but also strategic guidance to help them scale and succeed in competitive markets​.

Anterra Capital is a venture capital firm that specializes in investments within the food and agricultural technology sectors. Founded in 2013, Anterra Capital has offices in Amsterdam and Boston and focuses on backing innovative companies that address critical challenges in agriculture, food production, and sustainability. Their portfolio includes notable investments such as Enko Chem, which develops novel crop protection products; ProducePay, a financial and data services platform for the fresh produce industry; and BiomEdit, which focuses on microbiome innovation for animal health. The firm manages over $450 million in assets and typically invests in Series A or B rounds, with initial checks ranging from $1 to $10 million. Anterra is committed to leveraging biotechnology and digital solutions to transform the food system, improve consumer health, and enhance the livelihoods of farmers. Their investment strategy emphasizes impact and sustainability, aligning with their goal to create a resilient and sustainable food system. Anterra Capital has raised significant funds, including a $260 million second Global Food and Agriculture Technology Fund, which continues to support biotech and digital innovations in the agrifood sector​.

Antler is a globally renowned early-stage venture capital firm known as the "day zero investor," backing founders from the inception of their startups. With over 850 investments in 20+ countries, Antler has notable portfolio companies like Airalo, a global eSIM provider, and has recently raised a $60 million MENAP fund to further support startups in the Middle East, North Africa, and Pakistan region. Antler focuses on sectors including technology, fintech, and digital innovation, providing personalized coaching, co-founder matching, and follow-on funding. Key team members include Dr. Jonathan Doerr and Romain Assunção, leading regional activities from Riyadh and Duba

Anzu Partners is a venture capital firm founded in 2014, focusing on breakthrough industrial and life sciences technologies. Headquartered in Washington, D.C., with additional offices in Boston, San Diego, and Tampa, the firm manages over $1 billion in strategic assets across various funds and investment strategies. Anzu Partners has a robust portfolio of around 40 companies, including notable investments in e-Zinc, Framework, EnCharge, AM Batteries, and Arduino. The firm has also achieved significant exits, such as NUBURU and Ai-Media, highlighting its capability to support companies from early stages through to successful public offerings or acquisitions. Anzu specializes in three primary investment solutions: venture capital investments, debt and revenue-based investments, and Special Purpose Acquisition Companies (SPACs). The firm provides not just capital but also deep expertise in business development, market positioning, global connectivity, and operations, helping to drive the commercial success of its portfolio companies. The leadership team at Anzu Partners includes experienced professionals like Managing Partners David Michael, David Seldin, and Whitney Haring-Smith, who bring decades of combined experience in global investments and consultancy. This expertise is further supported by a dedicated team of technical and operational professionals.

Apax Partners is a leading global private equity advisory firm with a focus on inspiring growth and transforming businesses. Founded nearly 50 years ago, Apax has raised and advised over 30 funds, managing more than $77 billion in aggregate capital. The firm primarily invests in four sectors: Tech, Services, Healthcare, and Internet/Consumer. Apax operates several strategic funds, including Apax Global Buyout, which focuses on transformative growth in key sectors, and Apax Digital Growth, aimed at accelerating tech companies. Additionally, Apax Global Impact targets companies that deliver tangible societal and environmental benefits, while Apax Mid-Market Israel leverages local expertise to support growth in Israeli businesses. The firm also has Apax Credit and Apax Listed Private Equity strategies to provide a flexible investment approach across the capital structure​. Notable investments include Auto Trader Group, GlobalLogic, and Cole Haan, among others. Apax leverages its deep sector expertise and global network to drive operational excellence and digital transformation within its portfolio companies. The firm’s extensive experience and strategic focus have made it a prominent player in private equity globally, with offices in major financial hubs including London, New York, Hong Kong, and Tel Aviv​.

Applied Ventures is the venture capital arm of Applied Materials, based in Santa Clara, California. Since its establishment in 2006, the firm has focused on early-stage investments, primarily within deep technology sectors such as semiconductors, energy, advanced materials, and life sciences. Applied Ventures has a global reach, with investments spanning across North America, Europe, Asia-Pacific, and the Middle East. The firm is known for its flexibility, investing up to $100 million annually and actively participating in funding rounds ranging from $10 to $50 million. Its strategy emphasizes supporting startups with disruptive technologies by connecting them to Applied Materials' global ecosystem, which includes industry partners, supply chain resources, and technical expertise. Key portfolio companies include Ayar Labs (optical I/O technology), Rockley Photonics, and TXOne Networks, reflecting its focus on innovations that align with Applied Materials' core strengths in materials engineering and semiconductor technology​. The investment team is led by Anand Kamannavar, who serves as Global Head, alongside key figures such as Brad McManus, John Wei, and Rajesh Ramanujam, all based in Santa Clara. Applied Ventures is stage-agnostic, supporting both early and growth-stage startups as they scale globally, especially those involved in deep tech advancements.

Aramco Ventures is the corporate venture capital arm of Saudi Aramco, one of the world’s largest integrated energy and chemicals companies. Established in 2012, the fund has grown significantly, recently receiving an additional $4 billion, bringing its total capital to $7.5 billion. This expansion supports Aramco's long-term strategy of investing in technologies critical to energy transition and sustainability. Aramco Ventures operates through several specialized funds, including its Prosperity7 and Sustainability Fund, focusing on sectors such as carbon management, hydrogen, renewables, AI, and advanced materials. The firm has made over 140 investments globally, backing companies like Promethean Particles and Seeq that align with its strategic goals of advancing low-carbon and innovative technologies. The fund is headquartered in Dhahran, Saudi Arabia, and led by CEO Mahdi Aladel. It actively seeks out companies that can contribute to the global energy transition, emphasizing technologies that offer scalable solutions to the challenges facing the energy sector today​.

Aravis is a private equity firm based in Zurich, Switzerland, founded in 2001 by Jean-Philippe Tripet. The firm focuses on high-tech growth investments, primarily in the biotech, creative and digital, and industrial high-tech sectors. Aravis has sponsored multiple fund vintages and has deployed over USD 400 million across four funds. Aravis Growth I LP, their latest initiative, targets investments in established, innovative Swiss and European companies with significant growth potential. This fund aims to fill the gap in growth capital in the region by offering strategic advice, access to networks, and capital to accelerate companies through their growth phases​. The team at Aravis is composed of experienced professionals from various backgrounds, including finance, industry, and technology, providing a wealth of knowledge and expertise to support their portfolio companies. Their investment approach also integrates ESG criteria, aligning with several UN Sustainable Development Goals (SDGs).

Archimed Group, founded in 2014 and headquartered in Lyon, France, is a leading private equity firm specializing in the healthcare sector. The firm manages around €8 billion in assets and is focused on investing in small to midsize companies across seven key healthcare sectors, including Biopharma, MedTech, and Healthcare IT. Archimed’s strategy involves acquiring majority stakes in companies and working closely with them to accelerate growth, drive innovation, and expand internationally. Archimed has a strong track record, with its funds consistently ranking in the top decile for performance. The firm’s latest fund, MED Platform II, closed at €3.5 billion in 2023, making it the largest healthcare-only private equity fund raised by a European-based firm. This fund is primarily focused on mid-cap companies in Europe and North America, aiming to support healthcare leaders in scaling their operations through strategic acquisitions and capacity expansions. Archimed’s commitment to impact investing is evident through its alignment with sustainable development goals and its EURÊKA Foundation, which supports healthcare-related charitable initiatives. The firm’s unique blend of financial, medical, and operational expertise positions it as a key player in the global healthcare investment landscape.

Aleph VC, founded in 2013 and based in Tel Aviv, specializes in early-stage investments, primarily partnering with Israeli entrepreneurs. With $850 million under management, Aleph focuses on building meaningful companies and impactful global brands across various sectors, including fintech, digital health, cybersecurity, AI, and machine learning. Notable investments by Aleph include Lemonade, a full-stack global insurance company, and Melio, which provides digital payment tools for small businesses. Other prominent portfolio companies include Nexar, a dashcam and edge-AI platform for better driving, and Freightos, a digital freight marketplace. The firm has also seen significant exits, such as the acquisition of Raftt and the public offering of Freightos​. Aleph typically invests between $2 million and $12 million in seed and pre-seed stages, focusing on innovative companies poised for global expansion. The team, led by co-founders Michael Eisenberg and Eden Shochat, leverages their extensive network and expertise to provide strategic guidance and access to global markets, aiming to create long-term value for their portfolio companies.

Arix Bioscience is a global venture capital firm based in London, specializing in biotechnology investments. Founded in 2016, Arix focuses on backing early-stage companies that are developing breakthrough treatments and technologies in the life sciences sector. Their investment strategy targets ventures from late pre-clinical to clinical stages, emphasizing a diversified portfolio to mitigate risks inherent in biotech investments​. The firm has built a robust portfolio that includes companies like Autolus, a developer of CAR-T cell therapies for cancer, and Disc Medicine, which focuses on treatments for hematologic diseases. Arix has also been involved in significant financing rounds, such as the $50 million Series B for Evommune and Ensoma, highlighting their role in advancing innovative biotech startups. Arix operates a permanent capital model, allowing it to support its portfolio companies through market fluctuations without being bound by strict exit timelines. This approach enables them to provide sustained support to their investments, which is critical in the high-risk, high-reward biotech sector.

Arkley Brinc VC is a venture capital firm based in Warsaw, Poland, that focuses on early-stage investments in hardware-enabled startups, particularly in IoT, MedTech, and smart manufacturing sectors. The firm was established as a joint initiative between Arkley, a European pioneer in hardware investments, and Brinc, a global accelerator known for its deep connections in China’s manufacturing hubs. This partnership allows Arkley Brinc to offer startups not only capital but also a wealth of resources for product development, manufacturing, and global distribution. With a fund size of $15 million, Arkley Brinc invests up to $1 million per company, supporting them from the prototype stage through to IPO. The firm’s investments are concentrated in Poland and across Europe, leveraging its strategic networks to help startups scale effectively. Arkley Brinc has a strong track record, with over 50 projects supported and several successful exits and IPOs. The firm’s team consists of serial entrepreneurs and finance professionals with extensive experience in launching and scaling technology businesses. The Arkley Launchpad program is another key initiative, offering a highly individualized acceleration program designed to raise successful funding rounds and drive operational success. This program is tailored to the specific needs of each startup, providing access to a network of partners in prototyping, manufacturing, sales, and investment.

Arthur Ventures, established in 2008 and headquartered in Minneapolis, Minnesota, focuses on investing in early-stage B2B software companies across the U.S. and Canada. They emphasize backing startups located outside Silicon Valley, promoting innovation and growth in diverse regions. Arthur Ventures' portfolio includes a variety of successful companies. Notable investments feature DataCamp, an online data science training platform; Protenus, which offers patient data protection; and ThreatLocker, a zero-trust endpoint security solution. Other significant portfolio companies include Jane.app, a practice management software for health and wellness clinics, and CertifID, a network management software company. The firm has made over 102 investments and has seen 18 exits, with companies like Ionic and TINYpulse achieving successful outcomes. Arthur Ventures focuses on sectors such as SaaS, cybersecurity, fintech, and healthcare IT, providing capital and strategic support to help early-stage companies grow and succeed.

Asahi Kasei Ventures is the corporate venture capital arm of Asahi Kasei, a diversified Japanese conglomerate with major operations in materials, homes, and healthcare. The venture fund focuses on early-stage investments globally, with a particular emphasis on startups that align with Asahi Kasei's strategic interests, such as advanced materials, healthcare innovations, and sustainability technologies. The fund is particularly active in sectors like hydrogen energy, carbon management, and bio-based chemicals, supporting startups that contribute to environmental sustainability. Asahi Kasei Ventures operates from key locations including Tokyo, Düsseldorf, and Shanghai, ensuring a broad geographic reach to identify and support innovative technologies worldwide. Asahi Kasei Ventures not only provides financial support but also leverages the vast resources and expertise of the broader Asahi Kasei Group, which has over 287 subsidiaries and a significant global footprint. This enables startups in their portfolio to benefit from deep industry knowledge, extensive networks, and strategic partnerships to accelerate their growth and impact.

Ascent Energy Ventures is a Denver-based venture capital firm focused on the digital transformation of the energy industry. Founded in 2019 by David Forsberg, the firm specializes in late-seed to early Series A investments, targeting startups that leverage digital tools to address modern energy challenges. Ascent’s portfolio emphasizes innovations in sectors like IoT, SaaS, advanced materials, and energy technology, focusing on companies that have demonstrated revenue traction and product-market fit. The firm's strategy centers on identifying and supporting entrepreneurs who apply advanced digital solutions to optimize energy operations, infrastructure, and sustainability. Notable investments include Galatea Technologies, a software firm, and Iron-IQ, a leader in industrial IoT for energy operations. Ascent looks for companies positioned for growth and profitability, often targeting those on the verge of significant scaling. In 2024, Ascent raised $12 million in seed funding to bolster its energy tech portfolio. Led by a team with extensive experience in energy investment and technology, Ascent provides both financial backing and strategic guidance. Key team members include Jim Newell, with over 20 years of venture investment experience, and Chris Lang, who has a background in energy derivatives and advisory roles at major financial institutions. Ascent Energy Ventures is a crucial player in the evolving energy landscape, helping startups secure funding and navigate complex markets to achieve lasting impact..

Aster Capital, established in 2000 and based in Paris, is a venture capital firm specializing in Climate Tech investments. The firm focuses on sectors such as energy, mobility, and industry, supporting startups at various stages of development. Aster Capital manages around €500 million in assets and operates globally with offices in Paris, San Francisco, and Tel Aviv. Key investments by Aster include companies like ekWateur, an energy supplier accelerating the energy transition; Betterway, a pioneer in employee mobility solutions; and Iceotope, specializing in liquid cooling technologies for data centers. These investments reflect Aster’s commitment to supporting innovative solutions that contribute to carbon neutrality. Aster recently raised €240 million to invest in energy transition and future mobility projects, underscoring their dedication to driving significant environmental impact through technology. The firm’s strategy involves not only financial investment but also providing extensive support through their "Business Hub" approach, which facilitates business opportunities and partnerships for their portfolio companies​.

AstraZeneca is a leading global biopharmaceutical company with a strong focus on oncology, biopharmaceuticals, and rare diseases. They are committed to discovering, developing, and delivering innovative medicines that transform the lives of patients worldwide. AstraZeneca's oncology portfolio is particularly noteworthy, with a significant emphasis on creating groundbreaking cancer treatments. Their strategy includes leveraging various scientific platforms such as antibody-drug conjugates (ADCs), radioconjugates, and T cell engagers. Recent high-profile deals include collaborations with Daiichi Sankyo for ADCs and the acquisition of Neogene Therapeutics to enhance their T cell receptor therapy capabilities​​. In addition to oncology, AstraZeneca has a robust pipeline in biopharmaceuticals aimed at addressing chronic diseases and enhancing long-term health outcomes. They are also advancing treatments for rare diseases, expanding their reach globally to ensure broader access to their innovative therapies​​. AstraZeneca's business development approach is integral to their growth, focusing on strategic alliances and partnerships. This includes collaborations with companies like Tempus for AI-enabled precision medicine and various biotech firms to accelerate advancements in areas like epigenetics and undruggable targets​​. The company emphasizes a culture of innovation, diversity, and sustainability, aiming to make a significant impact on global health while maintaining environmental responsibility through initiatives like Ambition Zero Carbon​.

Atlas Venture is a leading venture capital firm specializing in early-stage investments in biotechnology and life sciences. Founded in 1980 and based in Cambridge, Massachusetts, Atlas Venture has built a robust portfolio by focusing on groundbreaking biotech innovations. The firm has raised multiple funds, including their most recent Fund XIII at $450 million, which emphasizes their commitment to fueling biotech startups from seed stage through to successful exits​. Notable investments in their portfolio include companies like Intellia Therapeutics, Kymera Therapeutics, and Ikena Oncology. These investments highlight Atlas Venture's dedication to developing therapies that address significant unmet medical needs, particularly in oncology and genetic disorders. Intellia Therapeutics, for instance, is renowned for its gene-editing technologies, while Kymera Therapeutics focuses on protein degradation to treat diseases. Atlas Venture has achieved numerous successful exits, such as the acquisitions of IFM Therapeutics by Bristol-Myers Squibb and Novartis, and the IPO of Generation Bio. These exits underscore the firm’s strategic capability in identifying and nurturing high-potential biotech startups to maturity. The firm is led by a team of experienced partners, including Jean-Francois Formela, Jason Rhodes, and David Grayzel, who bring a wealth of expertise in venture capital and life sciences. This team collaborates closely with entrepreneurs to provide not just capital but also strategic guidance and operational support, leveraging their extensive network within the biotech industry. For startups aiming to partner with Atlas Venture, it is crucial to present innovative solutions with strong scientific foundations and clear pathways to address significant medical challenges. The firm values startups that demonstrate potential for substantial clinical impact and scalability within the healthcare sector.

Audacia is a Paris-based private equity and venture capital firm, founded in 2006 by Charles Beigbeder. The firm focuses on a range of investment strategies, including venture capital, growth capital, and buyouts, primarily targeting high-tech, real estate, and consumer sectors. With a strong emphasis on innovation and technological advancement, Audacia has built a diverse portfolio of over 229 investments, including companies like Gamestream and Multiverse Computing. Audacia is particularly active in France, which accounts for the majority of its investments, though they also have a presence in other regions like the United Kingdom. The firm’s approach involves leading early-stage and Series A funding rounds, supporting startups through to later stages of growth. Audacia’s investment philosophy centers on backing visionary entrepreneurs and innovative companies that have the potential to disrupt their respective industries. The firm is led by a seasoned team of 20 professionals, including key figures such as Charles Beigbeder, Cedric James, and Vincent Brillault, who bring extensive experience in both the investment and operational aspects of the business. With its strategic focus and deep expertise, Audacia continues to play a significant role in shaping the European venture capital landscape​.